Reduced ACLY activity has modest acute cytotoxic effects if applied directly to cardiomyocytes, these cells being more sensitive to ACLY inhibition than what is reported from proliferative cells such as cancer, vascular smooth muscle cells, stem cells, or myofibroblasts. Here, ACLY is linked to cancer.